Merck under formal investigation in France over Thyroid Drug Levothyrox

Published On 2022-10-20 09:00 GMT   |   Update On 2022-10-20 09:00 GMT

Paris: Drugmaker Merck said on Wednesday it had been placed under formal investigation by a French court for possibly issuing misleading information regarding its thyroid drug product Levothyrox.Mario-Pierre Stasi, the lawyer for Merck, said the company would continue to co-operate with authorities on the matter and that full legal proceedings must be allowed to run their course.Merck said...

Login or Register to read the full article

Paris: Drugmaker Merck said on Wednesday it had been placed under formal investigation by a French court for possibly issuing misleading information regarding its thyroid drug product Levothyrox.

Mario-Pierre Stasi, the lawyer for Merck, said the company would continue to co-operate with authorities on the matter and that full legal proceedings must be allowed to run their course.
Merck said the ruling by a judge in the French city of Marseille did not concern in any way the new formula for the Levothyrox product, but the way the company provided information when changing from the old to the new formula.
In March 2022, France's highest court, the Cour de Cassation, confirmed a 2020 Lyon appeal court ruling ordering Merck to pay 1,000 euros ($982.30) each to compensate more than 3,300 people suffering from thyroid problems in France after it changed the formula of the drug in 2017.
The plaintiffs had accused Merck of not providing sufficient information regarding changes to the product.
They had said Merck's decision to remove lactose from the drug to make it easier to handle had resulted in side effects such as memory loss, weight gain, and palpitations.

Read also: Merck to develop personalized cancer vaccine in collaboration with Moderna

Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News